UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 48

Sortiert nach

Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737

Molecular cancer therapeutics, 2009-04, Vol.8 (4), p.883-892

2009

Link zum Volltext

Verfügbarkeit prüfen

Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer

Nature chemical biology, 2007-08, Vol.3 (8), p.498-507

2007

Link zum Volltext

Verfügbarkeit prüfen

The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor, NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of Chemotherapy

Clinical cancer research, 2005-02, Vol.11 (4), p.1563-1571

2005

Link zum Volltext

Verfügbarkeit prüfen

Activating c-kit Gene Mutations in Human Germ Cell Tumors

The American journal of pathology, 1999-06, Vol.154 (6), p.1643-1647

1999

Link zum Volltext

Verfügbarkeit prüfen

Teaching an old drug new tricks: Actinomycin D synergistically enhances sensitivity to the Bcl-2 antagonist ABT-737

Cancer biology & therapy, 2010-11, Vol.10 (9), p.930-932

Krystal, Geoffrey W.

2010

Link zum Volltext

Verfügbarkeit prüfen

Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression

Clinical cancer research, 2018-01, Vol.24 (2), p.360-369

2018

Link zum Volltext

Verfügbarkeit prüfen

Auer Rods

The New England journal of medicine, 2017-05, Vol.376 (21), p.2065-2065

2017

Link zum Volltext

Verfügbarkeit prüfen

Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1α activity and vascular endothelial growth factor expression in small cell lung cancer cells

Molecular cancer therapeutics, 2006-06, Vol.5 (6), p.1415-1422

2006

Link zum Volltext

Verfügbarkeit prüfen

Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer

Cancer biology & therapy, 2016-01, Vol.17 (1), p.27-35

2016

Link zum Volltext

Verfügbarkeit prüfen

The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling

Molecular cancer therapeutics, 2004-05, Vol.3 (5), p.527-536

2004

Link zum Volltext

Verfügbarkeit prüfen

Early FDG/PET scanning as a pharmacodynamic marker of anti-EGFR antibody activity in colorectal cancer

Molecular cancer therapeutics, 2012-07, Vol.11 (7), p.1385-1388

2012

Link zum Volltext

Verfügbarkeit prüfen

The Selective Tyrosine Kinase Inhibitor STI571 Inhibits Small Cell Lung Cancer Growth

Clinical cancer research, 2000-08, Vol.6 (8), p.3319-3326

2000

Link zum Volltext

Verfügbarkeit prüfen

Flavopiridol Potently Induces Small Cell Lung Cancer Apoptosis during S Phase in a Manner That Involves Early Mitochondrial Dysfunction

Clinical cancer research, 2003-10, Vol.9 (12), p.4586-4594

2003

Link zum Volltext

Verfügbarkeit prüfen

Receptor tyrosine kinase mutations: Molecular indicators for therapeutic response or signposts marking important signaling pathways?

Cancer biology & therapy, 2005-12, Vol.4 (12), p.1417-1418

Krystal, Geoffrey W.

2005

Link zum Volltext

Verfügbarkeit prüfen

Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt

Lung cancer (Amsterdam, Netherlands), 2008-05, Vol.60 (2), p.166-174

2008

Link zum Volltext

Verfügbarkeit prüfen

Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells

Cancer research (Baltimore), 2001-05, Vol.61 (9), p.3660-3668

2001

Link zum Volltext

Verfügbarkeit prüfen

Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor

Cancer research (Chicago, Ill.), 1996-01, Vol.56 (2), p.370-376

1996

Link zum Volltext

Verfügbarkeit prüfen

Imatinib mesylate (STI571) for myeloid malignancies other than CML

Leukemia research, 2004-05, Vol.28, p.53-59

Krystal, Geoffrey W

2004

Link zum Volltext

Verfügbarkeit prüfen

The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression

Lung cancer (Amsterdam, Netherlands), 2004-12, Vol.46 (3), p.283-291

2004

Link zum Volltext

Verfügbarkeit prüfen

Lck associates with and is activated by Kit in a small cell lung cancer cell line: Inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1

Cancer research (Chicago, Ill.), 1998-10, Vol.58 (20), p.4660-4666

1998

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of insulin/IGF-1 receptor signaling enhances bile acid toxicity in primary hepatocytes

Biochemical pharmacology, 2005-11, Vol.70 (11), p.1685-1696

2005

Link zum Volltext

Verfügbarkeit prüfen

Selective Sp1 binding is critical for maximal activity of the human c-kit promoter

Blood, 1998-12, Vol.92 (11), p.4138-4149

1998

Link zum Volltext

Verfügbarkeit prüfen

A novel assay for the measurement of Raf-1 kinase activity

Oncogene, 2000-10, Vol.19 (43), p.5030-5033

2000

Link zum Volltext

Verfügbarkeit prüfen

Identification of novel human tumor cell-specific CaMK-II variants

Biochimica et biophysica acta, 1997-03, Vol.1355 (3), p.281-292

1997

Link zum Volltext

Verfügbarkeit prüfen

Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors

Breast cancer research and treatment, 1999-11, Vol.58 (1), p.1-10

1999

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 48

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(48)

Sprache

Englisch
(48)
Japanisch
(6)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Alterations in the Noxa/Mcl-1 axis determine sensitivity of small cell lung cancer to the BH3 mimetic ABT-737

Selective compounds define Hsp90 as a major inhibitor of apoptosis in small-cell lung cancer

The Insulin-Like Growth Factor-I Receptor Kinase Inhibitor, NVP-ADW742, Sensitizes Small Cell Lung Cancer Cell Lines to the Effects of Chemotherapy

Activating c-kit Gene Mutations in Human Germ Cell Tumors

Teaching an old drug new tricks: Actinomycin D synergistically enhances sensitivity to the Bcl-2 antagonist ABT-737

Venetoclax Is Effective in Small-Cell Lung Cancers with High BCL-2 Expression

Auer Rods

Imatinib inhibits c-Kit-induced hypoxia-inducible factor-1α activity and vascular endothelial growth factor expression in small cell lung cancer cells

Combination with vorinostat overcomes ABT-263 (navitoclax) resistance of small cell lung cancer

The insulin-like growth factor-I (IGF-I) receptor kinase inhibitor NVP-ADW742, in combination with STI571, delineates a spectrum of dependence of small cell lung cancer on IGF-I and stem cell factor signaling

Early FDG/PET scanning as a pharmacodynamic marker of anti-EGFR antibody activity in colorectal cancer

The Selective Tyrosine Kinase Inhibitor STI571 Inhibits Small Cell Lung Cancer Growth

Flavopiridol Potently Induces Small Cell Lung Cancer Apoptosis during S Phase in a Manner That Involves Early Mitochondrial Dysfunction

Receptor tyrosine kinase mutations: Molecular indicators for therapeutic response or signposts marking important signaling pathways?

Selective inhibition of SCLC growth by the A12 anti-IGF-1R monoclonal antibody correlates with inhibition of Akt

Indolinone tyrosine kinase inhibitors block Kit activation and growth of small cell lung cancer cells

Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor

Imatinib mesylate (STI571) for myeloid malignancies other than CML

The multi-targeted kinase inhibitor SU5416 inhibits small cell lung cancer growth and angiogenesis, in part by blocking Kit-mediated VEGF expression

Lck associates with and is activated by Kit in a small cell lung cancer cell line: Inhibition of SCF-mediated growth by the Src family kinase inhibitor PP1

Inhibition of insulin/IGF-1 receptor signaling enhances bile acid toxicity in primary hepatocytes

Selective Sp1 binding is critical for maximal activity of the human c-kit promoter

A novel assay for the measurement of Raf-1 kinase activity

Identification of novel human tumor cell-specific CaMK-II variants

Coexpression of c-kit and stem cell factor in breast cancer results in enhanced sensitivity to members of the EGF family of growth factors

Suchergebnisse filtern